Cementos Bio Bio Statistics

Total Valuation

Cementos Bio Bio has a market cap or net worth of CLP 423.02 billion. The enterprise value is 541.34 billion.

Market Cap	423.02B
Enterprise Value	541.34B

Important Dates

The last earnings date was Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	Dec 23, 2024

Share Statistics

Cementos Bio Bio has 264.22 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	264.22M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	10.41%
Float	46.70M

Valuation Ratios

The trailing PE ratio is 12.86.

PE Ratio	12.86
Forward PE	n/a
PS Ratio	1.17
PB Ratio	1.54
P/TBV Ratio	1.66
P/FCF Ratio	12.50
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.49, with an EV/FCF ratio of 15.99.

EV / Earnings	16.45
EV / Sales	1.50
EV / EBITDA	8.49
EV / EBIT	12.69
EV / FCF	15.99

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.48.

Current Ratio	1.59
Quick Ratio	0.85
Debt / Equity	0.48
Debt / EBITDA	2.07
Debt / FCF	3.89
Interest Coverage	3.42

Financial Efficiency

Return on equity (ROE) is 12.58% and return on invested capital (ROIC) is 6.84%.

Return on Equity (ROE)	12.58%
Return on Assets (ROA)	5.42%
Return on Capital (ROIC)	6.84%
Revenue Per Employee	370.15M
Profits Per Employee	33.78M
Employee Count	1,142
Asset Turnover	0.73
Inventory Turnover	3.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +138.96% in the last 52 weeks. The beta is 0.17, so Cementos Bio Bio's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	+138.96%
50-Day Moving Average	1,046.71
200-Day Moving Average	785.25
Relative Strength Index (RSI)	97.65
Average Volume (20 Days)	228,447

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cementos Bio Bio had revenue of CLP 360.52 billion and earned 32.90 billion in profits. Earnings per share was 124.52.

Revenue	360.52B
Gross Profit	139.94B
Operating Income	42.64B
Pretax Income	40.56B
Net Income	32.90B
EBITDA	50.23B
EBIT	42.64B
Earnings Per Share (EPS)	124.52

Full Income Statement

Balance Sheet

The company has 14.03 billion in cash and 131.69 billion in debt, giving a net cash position of -117.65 billion or -445.27 per share.

Cash & Cash Equivalents	14.03B
Total Debt	131.69B
Net Cash	-117.65B
Net Cash Per Share	-445.27
Equity (Book Value)	274.51B
Book Value Per Share	1,036.39
Working Capital	53.24B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 50.63 billion and capital expenditures -16.79 billion, giving a free cash flow of 33.85 billion.

Operating Cash Flow	50.63B
Capital Expenditures	-16.79B
Free Cash Flow	33.85B
FCF Per Share	128.10

Full Cash Flow Statement

Margins

Gross margin is 38.82%, with operating and profit margins of 11.83% and 9.13%.

Gross Margin	38.82%
Operating Margin	11.83%
Pretax Margin	11.25%
Profit Margin	9.13%
EBITDA Margin	13.93%
EBIT Margin	11.83%
FCF Margin	9.39%

Dividends & Yields

This stock pays an annual dividend of 36.00, which amounts to a dividend yield of 2.25%.

Dividend Per Share	36.00
Dividend Yield	2.25%
Dividend Growth (YoY)	84.00%
Years of Dividend Growth	n/a
Payout Ratio	28.87%
Buyback Yield	n/a
Shareholder Yield	2.25%
Earnings Yield	7.78%
FCF Yield	8.00%

Dividend Details

Stock Splits

The last stock split was on July 17, 1995. It was a forward split with a ratio of 10.

Last Split Date	Jul 17, 1995
Split Type	Forward
Split Ratio	10

Scores

Cementos Bio Bio has an Altman Z-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2
Piotroski F-Score	n/a